Biosimilars
Biotech
Pfizer Reports Results of PF-05280586 (rituximab biosimilar) in REFLECTIONS B328-06
Shots: The REFLECTIONS B328-06 study involves assessing of PF-05280586 vs Rituxan/MabThera (rituximab) in patients with 1L CD20-positive, low tumor burden, follicular lymphoma evaluating its efficacy, safety and immunogenicity, PK and […]readmore